Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
CAR T Cells Show Solid Progress
Tumors are Being Deprived of Cover by New CAR T-Cell Technologies
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
For full access to this article login to GEN Select now.
Bending the Cost and Time Curve of Drug Development through the Use of Biomarkers
- The right biomarker can make all the difference in a drug-development program, allowing a clinical trial to enroll a smaller patient population, lowering costs, and shortening timelines. As much as the right biomarker might be desired, it might not exist. It might need to be discovered and developed. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.